An international team of scientists has succeeded in using a magnetic field to act on structures located deep in the brain.
The researchers injected magnetic nanoplates into the corresponding region, thereby managing to treat motor deficits in model mice that exhibited symptoms similar to those of Parkinson's disease.
According to the authors of the study, who published their findings in the journal Advanced Science, this new approach is less invasive than the standard stimulation procedures —which use implanted electrodes— currently used to treat certain patients with Parkinson's.
The work was led by specialists from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU, Germany), RWTH Aachen University (Germany), and the universities of Maastricht (Netherlands) and Leuven (Belgium).
According to the team, in the future, the method they have developed could become an alternative for certain patients, as it allows acting on deep regions of the brain without the need to permanently implant electrodes.
What is the treatment under development that uses magnetic fields and could help fight Parkinson's
Professor Danijela Gregurec, from the Department of Chemistry and Pharmacy at FAU, is one of the authors of the study.
In a statement, she explained that they used magnetic nanoparti…
AI Brief
Your highlights
An international team of scientists has succeeded in using a magnetic field to act on structures located deep within the brain. The researchers injected magnetic nanoplates into the corresponding region, thereby managing to treat motor deficits in model mice that exhibited symptoms similar to those of Parkinson's disease. According to the authors of the study, who published their findings in the journal Advanced Science, this new approach is less invasive than the standard stimulation procedures —which use implanted electrodes— currently employed to treat certain Parkinson's patients. The work was led by specialists from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU, Germany), RWTH Aachen University (Germany), and the universities of Maastricht (Netherlands) and Leuven (Belgium). According to the team, in the future, the method they have developed could become an alternative for certain patients, as it allows acting on deep regions of the brain without the need to permanently implant electrodes. Scientists develop a magnetic field treatment that could help combat Parkinson's, according to a study. Photo: referential What is the treatment under development that uses magnetic fields and could help combat Parkinson's? Professor Danijela Gregurec, from the Department of Chemistry and Pharmacy at FAU, is one of the authors of the study. In a statement, she explained that they used magnetic nanoparticles that they implanted in the brain, which "have a special shape and a magnetic structure." "They have been designed to transform magnetic fields into tiny mechanical forces," said Dr. Gregurec, adding that this is the fundamental difference between this approach and traditional deep brain stimulation via "pacemakers." "The conventional method establishes an electrical connection with the brain. We, on the other hand, take advantage of the natural mechanosensors of neurons to influence regions located deep within the brain." If a magnetic field is generated around the brain, the nanoparticles react by creating tiny mechanical forces. These forces can slightly deform the cell membranes of their surroundings, similar to what happens when pressing an inflated balloon with an index finger. This causes the opening of small mechanosensitive channels, allowing charged ions to penetrate the nerve cells, said the scientist. The research groups participating in the project tested their methods in animal models. In the specimens used for the experiments, the same nerve cells were damaged as in human patients with Parkinson's, which led to similar motor deficiencies. "In collaboration with our partners in Maastricht, we injected magnetic nanoparticles developed here, at FAU, into the subthalamic nucleus of the animals. This is precisely the brain region that constitutes a key target for conventional deep brain stimulation in Parkinson's disease." The particles were injected using high-precision stereotactic methods, which allowed them to be placed exactly in the required brain region, said Dr. Gregurec. She stated that when the animals were exposed to a magnetic field, a significant improvement in their motor deficits was observed. In her words: "The effect is approximately equivalent to what one would expect after the implantation of a brain 'pacemaker'." The magnetic particles remained in the brain for a test period of several months. During that time, no signs of inflammation appeared, according to the researchers. Now, Dr. Gregurec's team is looking for even less invasive methods that would make it possible to dispense with direct injection into the brain. Along with this, the group is exploring the development of small portable devices capable of generating the magnetic fields necessary for this stimulation. Despite their recent findings, they state that it will probably be years before these approaches can be considered for use in clinical practice. "Even so, we are convinced that this new method has enormous potential. Not only is it considerably simpler and cheaper than a conventional brain 'pacemaker', but it is probably also more flexible. Adjusting the parameters of the magnetic field would allow us to control the nanoparticles with greater precision," concluded Dr. Gregurec. It is worth remembering that if you have health-related questions, it is always advisable to consult with specialists to evaluate your particular case and the best ways to address it.